FDA bans import of Indian Pharmaceuticals
Marketplace reports that the FDA has blocked sales from one of India’s largest drug producers, Ranbaxy Pharmaceuticals. “It prevented sales of Ranbaxy’s generic versions of the antibiotic Cipro and the cholesterol pill Zocor.” This begs the question: should the FDA put office in foreign countries? On the one hand, it is important to ensure that imported…